SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BARALDI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.502
EU - Europa 3.336
AS - Asia 1.943
SA - Sud America 381
AF - Africa 65
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.236
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.423
FI - Finlandia 1.981
SG - Singapore 621
CN - Cina 540
BR - Brasile 305
DE - Germania 290
VN - Vietnam 269
IT - Italia 257
PL - Polonia 205
HK - Hong Kong 138
GB - Regno Unito 130
TR - Turchia 129
UA - Ucraina 105
SE - Svezia 89
FR - Francia 81
RU - Federazione Russa 72
IN - India 49
CA - Canada 41
JP - Giappone 37
ID - Indonesia 33
BD - Bangladesh 31
ZA - Sudafrica 31
MX - Messico 28
BE - Belgio 26
AR - Argentina 23
NL - Olanda 23
IQ - Iraq 19
ES - Italia 18
AT - Austria 15
CL - Cile 13
EG - Egitto 12
CO - Colombia 11
UZ - Uzbekistan 11
EC - Ecuador 10
IL - Israele 7
PK - Pakistan 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
TW - Taiwan 6
UY - Uruguay 6
VE - Venezuela 6
AU - Australia 5
CH - Svizzera 5
LT - Lituania 5
PY - Paraguay 5
SA - Arabia Saudita 5
IE - Irlanda 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
NP - Nepal 4
BG - Bulgaria 3
BY - Bielorussia 3
MA - Marocco 3
PH - Filippine 3
RO - Romania 3
AL - Albania 2
AZ - Azerbaigian 2
CR - Costa Rica 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
IR - Iran 2
KH - Cambogia 2
MD - Moldavia 2
MN - Mongolia 2
MY - Malesia 2
PT - Portogallo 2
TH - Thailandia 2
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GL - Groenlandia 1
HN - Honduras 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MC - Monaco 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 10.234
Salva come PNG Salva come JPEG
Città #
Helsinki 1.931
Dallas 771
Ashburn 490
Singapore 427
Fairfield 360
Woodbridge 354
Ann Arbor 207
San Jose 204
Warsaw 201
Beijing 185
Chandler 178
Houston 172
Santa Clara 145
Seattle 144
Wilmington 138
Hong Kong 131
Jacksonville 123
Cambridge 120
Ferrara 108
Ho Chi Minh City 77
Los Angeles 77
Munich 74
Izmir 58
Hanoi 56
New York 47
Shanghai 43
Milan 40
Council Bluffs 39
Nanjing 38
Tokyo 37
Princeton 34
Dong Ket 31
Boardman 29
London 29
São Paulo 29
Brussels 26
Lauterbourg 26
Turku 25
San Diego 23
Orem 21
Bremen 19
Frankfurt am Main 19
Jakarta 19
Addison 18
Brooklyn 16
Amsterdam 15
Chicago 15
Asnières-sur-Seine 14
Shenyang 14
Montreal 13
Nanchang 13
Stockholm 13
Toronto 12
Baghdad 11
Denver 11
Haiphong 11
Jiaxing 11
Mexico City 11
Atlanta 10
Changsha 10
Chennai 10
Des Moines 10
Hebei 10
Johannesburg 10
Phoenix 10
Poplar 10
Tashkent 10
Buffalo 9
Cairo 9
Curitiba 9
Da Nang 9
Moscow 9
Querétaro 9
Rio de Janeiro 9
Ankara 8
Brasília 8
Falls Church 8
Tianjin 8
Belo Horizonte 7
Hefei 7
Mcallen 7
Redwood City 7
San Francisco 7
Washington 7
Biên Hòa 6
Boston 6
Cape Town 6
Cergy 6
Guangzhou 6
Hải Dương 6
Jinan 6
Manchester 6
Montevideo 6
Montréal 6
Mumbai 6
Norwalk 6
Santiago 6
Auburn Hills 5
Columbus 5
Guarulhos 5
Totale 7.823
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 3.087
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 328
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 308
Design and Synthesis of New A2B Adenosine Receptor Antagonists 297
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents 288
2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition 287
A3 adenosine receptor antagonists: History and future perspectives 283
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 280
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 273
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 261
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 256
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 245
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 237
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 236
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 236
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 223
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 220
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 207
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 201
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 199
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 186
Synthesis and biological evaluation of alpha-bromoacryloylamido indolyl pyridinyl propenones as potent apoptotic inducers in human leukaemia cells 172
Adenosine Receptors in Colon Carcinoma Tissues and Colon Tumoral Cell Lines: Focus on the A3 Adenosine Subtype 155
3-Aryl/Heteroaryl-5-amino-1-(3′,4′,5′-trimethoxybenzoyl)-1,2,4-triazoles as antimicrotubule agents. Design, synthesis, antiproliferative activity and inhibition of tubulin polymerization 155
A 2a adenosine receptor: Structures, modeling, and medicinal chemistry 155
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 155
Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2B Adenosine Receptor Antagonists 137
Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonists. 122
null 121
Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors 120
Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB2 Cannabinoid Receptor Partial Agonists 119
null 118
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists 115
null 103
null 96
Synthesis and Biological Evaluation of Novel 2-Amino-3-Aroyl-4-Neopentyl-5-Substituted Thiophene Derivatives as Allosteric Enhancers of the A1 Adenosine Receptor 92
null 90
null 84
null 83
Totale 10.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.878
Totale 34.418
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021242 0 0 0 0 0 0 0 0 0 121 62 59
2021/2022441 26 25 34 25 36 34 23 24 27 40 36 111
2022/2023438 41 59 8 67 58 55 37 33 47 2 21 10
2023/2024273 19 21 13 9 32 61 8 34 2 6 4 64
2024/20251.063 30 50 92 47 102 96 73 63 144 74 149 143
2025/20265.340 313 308 784 361 442 238 373 159 2.118 244 0 0
Totale 10.330